Alzheimer’s drug shows promise in early patient trials Phase I trial results show verubecestat reduced levels of beta-amyloid in patients with Alzheimer’s disease.…
New treatment option for Parkinson’s disease launched in the UK Drug company BIAL Pharm UK has launched opicapone (Ongentys), a new drug to improve mobility in some adult patients with Parkinson’s disease, for use in the UK. …
Alemtuzumab reduces disability in patients with MS A drug used to treat multiple sclerosis (MS) can reverse some of the physical disabilities created by the neurological disease, according to new research.…
Widely used NSAID treats Alzheimer’s disease in mice The anti-inflammatory drug mefenamic acid can reverse memory loss and brain inflammation in a mouse model of Alzheimer’s disease, a study shows.…
Early treatment may benefit patients with MS Researchers have discovered that starting treatment for multiple sclerosis when patients first show possible symptoms may prolong the time before the disease is clinically diagnosed.…
Deuterated drug shows promise in Huntington diseaseA modified version of a currently used drug for Huntington disease offers a promising efficacy and safety profile, according to a phase III study. …
First self-administered monthly injection for multiple sclerosis approved in the US Zinbryta (daclizumab), the first once-monthly self-administered injection for multiple sclerosis (MS), has been approved by the US Food and Drug Administration.…
Meet the regional finalists of I Love My Pharmacist: Midlands and East The public has until 21 July 2016 to vote for their favourite regional finalist of the 2016 I Love My Pharmacist Award. The pharmacist with the highest number of votes in each region will then meet with the judging panel who will decide the 2016 champion.…
FDA approves pimavanserin to treat hallucinations and delusions in Parkinson’s disease A drug to treat hallucinations and delusions in patients with Parkinson’s disease is being made available in the United States.…
OTC antihistamine shows potential to repair MS nerve damage Study results suggest clemastine could reduce optic nerve damage seen in multiple sclerosis.…